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While disordered to ordered rearrangements are
relatively common, the ability of proteins to switch
from one ordered fold to a completely different
fold is generally regarded as rare, and few fold
switches have been characterized. Here, in a de-
signed system, we examine the mutational require-
ments for transitioning between folds and functions.
We show that switching between monomeric 3a
and 4b+a folds can occur in multiple ways with
successive single amino acid changes at diverse
residue positions, raising the likelihood that such
transitions occur in the evolution of new folds. Even
mutations on the periphery of the core can tip the
balance between alternatively folded states. Ligand-
binding studies illustrate that a new immunoglobulin
G-binding function can be gained well before the
relevant 4b+a fold is appreciably populated in the
unbound protein. The results provide new insights
into the evolution of fold and function.
INTRODUCTION
Some proteins can adopt more than one folded state and have
been termed ‘‘metamorphic’’ (Murzin, 2008). Prions are a classic
example of the malleability of polypeptide chains, where confor-
mational change from a benign, predominantly a-helical form to
an infectious, b-strand-rich state is driven by multimerization
(Weissmann, 2005). However, there are a small but growing
number of other naturally occurring examples such as lympho-
tactin (Tuinstra et al., 2008), Mad2 (Luo and Yu, 2008; Mapelli
and Musacchio, 2007), and CLIC1 (Littler et al., 2004), suggest-
ing that the phenomenon of fold switching may be more general.
In these proteins, the equilibrium is shifted from one fold
topology to another by changes in environmental factors such
as salt conditions, the presence of a ligand, and redox state.
Other studies, such as those on the Cro family of repressors
(Roessler et al., 2008) and RfaH (Belogurov et al., 2009), support
the idea that some folds may have resulted from switching an
existing structure rather than evolving independently. Common
features of such switchable folds are (1) flexible regions andStructure 20, 28diminished stability to allow large-scale changes, (2) a fair degree
of mutual exclusivity in the core regions, and (3) the generation of
a new binding surface that stabilizes the alternative fold and
expands function (Bryan and Orban, 2010). Furthermore, theo-
retical studies predict that the sequences encoding certain
protein folds are switchable to numerous other folds and that
protein fold space may be more interconnected than previously
considered (Meyerguz et al., 2007).
In addition to natural examples of fold switches, protein design
has been used to investigate the question of how high the amino
acid sequence identity of two proteins can be while maintaining
different fold topologies (Ambroggio and Kuhlman, 2006; Rose
and Creamer, 1994). Some of the earlier studies in this area
showed that sequence identities of 50% or more could be
achieved but that aggregation became a problem at higher iden-
tities, making biophysical characterization difficult (Blanco et al.,
1999; Dalal and Regan, 2000). More recently, a binary system
was designed where different fold topologies were obtained
with very high (>85%) sequence identities (Alexander et al.,
2007, 2009; He et al., 2008). The starting points were two small
56-amino-acid domains, termed GA and GB, from the multido-
main Streptococcus cell surface protein G (Fahnestock et al.,
1986). The GA domain adopts a 3-a helix bundle (3a) structure
(Johansson et al., 1997) and binds human serum albumin
(HSA) (Falkenberg et al., 1992), whereas the GB domain has
a 4b+a fold (Gronenborn et al., 1991) and binds immunoglobulin
G (IgG) (Myhre and Kronvall, 1977). The albumin- and IgG-
binding epitopes (Sauer-Eriksson et al., 1995; Lejon et al.,
2004) were engineered into both domains, creating latent
binding sites that could be exposed on fold switching. The GA
and GB sequences were then co-evolved with site-directed
mutagenesis and phage display, increasing identity at muta-
tion-tolerant sites using binary sequence space (i.e., only GA or
GB amino acids) (Alexander et al., 2007). Nuclear magnetic reso-
nance (NMR) structures were determined for 88% (He et al.,
2008) and 95% (Alexander et al., 2009) identity protein pairs
while still maintaining different folds and functions.
The ability of proteins to switch folds is generally regarded as
rare and relatively few have been characterized structurally. One
possible reason why there are not more reports is that the
sequences of many such proteins may be inherently transient
and rapidly evolve to their new functions and folds. The designed
GA/GB system therefore provides an opportunity to examine
the mutational requirements for transitioning between folds
and functions. Here, we describe the three-dimensional (3D)3–291, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 283
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Figure 1. Single Amino Acid Mutations Leading to Fold Switching
(A) Alignment of amino acid sequences for the four proteins in this study, highlighting the positions at which changes lead to switching between 3a and 4b+a
folds.
(B) 2D 15N-HSQC spectra for GA98 (left), GB98 (center left), GB98-T25I (center right), and GB98-T25I,L20A (right). Viewing NMR spectra from left to right, large
differences are observed from one spectrum to the next as the three successive single site mutations, L45Y, T25I, and L20A, are made (see also Figure S1).
(C) Representative structures from the NMR ensembles of GA98, GB98, GB98-T25I, and GB98-T25I,L20A. Residues mutated are highlighted.
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Switching Protein Folds and Functionsstructures for a series of high sequence identity GA/GB mutants,
each being 98% identical to the next in the series. We show that
the folds of these proteins switch between 3a and 4b+a with
successive single amino acid changes at diverse residue posi-
tions and that there is a near-complete (R95%) shift in the
equilibrium between the two states. Thus, the pathway for fold
switching is not unique, raising the probability of such events
occurring. Moreover, ligand-binding studies on these high
sequence identity mutants illustrate that changes in fold and
function are not perfectly correlated. In our designed system,
fold switching can be abrupt, occurring with a single amino
acid mutation. However, the characteristics of a new binding
function can be displayed well before the corresponding fold is
appreciably populated in the unbound proteins. Overall, the
results presented here provide insights into how different folds284 Structure 20, 283–291, February 8, 2012 ª2012 Elsevier Ltd All rcan be closely connected in sequence space and how new
functions can evolve.
RESULTS
Description of Fold Topologies
The amino acid sequences of the four proteins described in this
study, GA98, GB98, GB98-T25I, and GB98-T25I,L20A, are shown
in Figure 1A, highlighting the single residue positions of noniden-
tity. Thus, GA98 is converted to GB98 by mutating L45 to Y45, a
T25I mutation changes GB98 to GB98-T25I, andGB98-T25I,L20A
is generated through an amino acid change at position 20 of
GB98-T25I. Although the sequences of these proteins are nearly
identical, the single amino acid mutation from one protein to the
next leads to significant differences in NMR spectra, reflectingights reserved
Table 1. Summary of Structure Statistics
Variable GA98 GB98 GB98-T25I
a GB98-T25I,L20A
Experimental restraints
NOE restraints
All NOEs 816 648 1,067
Intraresidue 507 395 627
Sequential (ji-jj = 1) 165 119 214
Medium range (1 < ji-jj% 5) 78 43 57
Long range (ji-jj > 5) 66 91 169
Hydrogen bond restraints 50 62 62
Dihedral angle restraints 72 64 64
Total NOE restraints 938 774 1,193
CS-Rosetta inputa
13Ca shifts 39
13Cb shifts 18
13C’ shifts 43
15N shifts 47
1HN shifts 47
1Ha shifts 42
RMSDs to the mean structure (A˚)
Over all residuesb
Backbone atoms 0.35 ± 0.10 0.81 ± 0.19 1.00 ± 0.27 0.61 ± 0.13
Heavy atoms 1.15 ± 0.16 1.66 ± 0.23 1.71 ± 0.35 1.44 ± 0.23
Secondary structuresc
Backbone atoms 0.31 ± 0.09 0.55 ± 0.14 0.96 ± 0.26 0.32 ± 0.07
Heavy atoms 1.12 ± 0.15 1.24 ± 0.16 1.72 ± 0.35 0.94 ± 0.13
Measures of structure quality
Ramachandran distribution
Most favored (%) 85.1 ± 3.9 75.6 ± 3.7 95.2 ± 2.1 77.7 ± 3.1
Additionally allowed (%) 12.5 ± 3.7 21.6 ± 4.5 4.8 ± 2.1 20.3 ± 3.7
Generously allowed (%) 0.6 ± 0.9 1.9 ± 1.4 0.0 ± 0.0 1.4 ± 1.4
Disallowed (%) 1.8 ± 1.3 0.9 ± 1.0 0.0 ± 0.0 0.6 ± 1.1
Bad contacts/100 residues 3.3 ± 1.1 1.0 ± 1.1 0.5 ± 0.7 1.5 ± 1.2
Overall dihedral G factor 0.08 ± 0.03 0.04 ± 0.03 0.41 ± 0.03 0.01 ± 0.02
aCS-Rosetta model based on assigned chemical shifts.
bResidues 1–56 for GB98 and GB98-T25I,L20A. Residues 9–51 for GA98 and GB98-T25I.
c The secondary structure elements used were as follows: GB98 and GB98-T25I,L20A, residues 1–8, 13–20, 23–36, 42–46, and 51–55; GA98, residues
9–23, 27–34, and 39–51; and GB98-T25I, residues 9–23, 28–34, and 39–52.
Structure
Switching Protein Folds and Functionslarge-scale alterations in 3D structure. Spectra in the first and
third panels of Figure 1B have cross-peak patterns typical of
other 3a folded proteins in this series, whereas the spectra in
the second and fourth panels are characteristic of a 4b+a fold
topology. To more quantitatively describe the effect of these
mutations, we obtained NMR assignments for these proteins
using heteronuclear triple resonance NMR spectroscopy and
3D structures were determined. All four proteins are monomeric
under NMR conditions from size exclusion chromatography
and light-scattering measurements. GA98, GB98, GB98-T25I,
and GB98-T25I,L20A have a melting temperature (Tm) of 37
C,
35C, 36C, and 46C, respectively. Because of the relatively
low stabilities, NMR spectra were recorded at 5C. Figure 1C
shows representative structures from each NMR ensemble,
highlighting the amino acid differences between proteins.Structure 20, 28Complete structure statistics are summarized in Table 1, and
the NMR ensembles for all four proteins are shown in Figure 2.
The Protein Data Bank/BioMagResBank accession codes for
GA98, GB98, GB98-T25I, and GB98-T25I,L20A are 2LHC/17839,
2LHD/17840, 2LHG/17843, and 2LHE/17841, respectively.
GA98 (3a)
The GA98 fold has a 3a-helical bundle topology similar to previ-
ously determined 3D structures of the original parental GA
sequence (He et al., 2006), GA88 (He et al., 2008), and GA95
(Alexander et al., 2009). Therefore, as the GA sequences are
co-evolved with GB sequences to high identity levels, the 3a
structures of the designed proteins do not veer significantly
from the wild-type fold topology. A comparison of the pairwise
backbone root-mean-square deviations (RMSDs) is shown in3–291, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 285
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Figure 3. Structural Changes in Going from 95% to 98% Sequence
Identity
(A) GA95 to GA98. A representative structure from the NMR ensemble for GA98,
highlighting some of the hydrophobic core residues (pale orange) and the
position of F30 relative to the core. By comparison, the position of I30 in GA95
is also shown (green). The main chain is in gray.
(B) GB95 to GB98. A representative NMR structure of GB98 highlighting the
A20L mutation site region in going from GB95 to GB98. GB98 side-chain
positions (pale orange) are compared with the corresponding GB95 confor-
mations (green).
Figure 2. NMR Structures of the Designed Proteins GA98, GB98,
GB98-T25I, and GB98-T25I,L20A
(A) Comparison of the 3a structures for GA98 (blue) and GB98-T25I (gold). The
NMR ensemble for GA98 consists of 20 final structures. The GB98-T25I
structure was determined with CS-Rosetta and main-chain chemical shift
assignments and is represented by an ensemble of 10 final structures (see also
Table S1).
(B) Comparison of the 4b+a structures for GB98 (blue) and GB98-T25I,L20A
(gold). Both NMR ensembles are of 20 final structures (see also Table S2).
Structure
Switching Protein Folds and FunctionsTable S1 (available online). TheN terminus from residues 1–8 and
the C terminus from residues 52–56 are disordered with helices
from residues 9–23, residues 27–34, and residues 39–51. Over-
all, the hydrophobic core interactions in GA98 are similar to those
in GA95 and GA88. Core residues in GA98 are as follows: A12,
A16, and A20 (a1-helix); I33 and A36 (a2-helix); and V42, K46,
and I49 (a3-helix). The only difference in amino acid sequence
in going from GA95 to GA98 is mutation of I30 to F30. Where
I30 contributes to the core of GA95 and is 17% solvent acces-
sible, F30 has limited interactions with the GA98 core through its
b-methylene group and has a solvent-exposed aromatic ring
(Figure 3A). The I30F mutation is therefore expected to be desta-
bilizing based on the GA98 structure. Indeed, the structural data
is consistent with stability measurements, which show that
an I30F mutation destabilizes the 3a fold by 1.5 kcal/mol
(Alexander et al., 2009).
GB98 (4b+a)
A single amino acid change in GA98, L45Y, generates the GB98
sequence, and the fold of this polypeptide chain is 4b+a rather
than 3a. The differences between the GA98 and GB98 structures
are striking. Residues that were at the unstructured ends of the
GA98 sequence form the central b strands, b1 and b4, of the
GB98 fold. Residues in the a1- and a3-helices of GA98 corre-
spond with the loop-b2-loop and loop-b3-loop-earlyb4 regions
of GB98, respectively. Comparison of the structure of GB98
with previous structures of the parent GB sequence (Gallagher
et al., 1994), GB88 (He et al., 2008), and GB95 (Alexander et al.,
2009), indicates very similar overall 4b+a fold topologies (Table
S2). A single amino acid change from an alanine at position 20
to a leucine increases the identity from GB95 to GB98. The steri-
cally more demanding leucine at position 20 is accommodated in
the 4b+a fold with slight adjustments of the backbone and neigh-
boring side-chain conformations (Figure 3B). Nevertheless, the286 Structure 20, 283–291, February 8, 2012 ª2012 Elsevier Ltd All rincorporation of the branched side chain at L20 does lead to
increased steric clashes with adjacent residues, consistent
with a decrease in Tm of GB98 by 12
C relative to GB95 (Alex-
ander et al., 2009).
GB98-T25I (3a)
For GB98-T25I, de novo structure determination with extensive
Nuclear Overhauser Effect (NOE) restraints was not possible
because of low sample solubility (<100 mM), which prevented
complete assignments particularly of side-chain resonances.
However, assignment of a significant proportion of main-chain
15N, 1HN, 1Ha, 13Ca, and 13C’ resonances (Table 1), as well as
some 13Cb signals, showed three distinct helical regions by
consensus chemical shift index analysis (Wishart and Sykes,
1994). Comparison of backbone 1HN and 15N shifts showed
a much closer match with those of GA98 rather than GB98 (Fig-
ure S1), indicating that fold switching from a 4b+a to 3a confor-
mation had occurred with the T25I mutation. Furthermore, a 3D
structure was calculated from these experimental chemical
shifts using the CS-Rosetta algorithm (Shen et al., 2008). We
previously used CS-Rosetta to determine structures for GA88,
GB88, GA95, and GB95 and found that these structures
compared well (backbone RMSDs 1.0–1.5 A˚) with the struc-
tures calculated from mostly NOE restraint data (Shen et al.,
2010). The CS-Rosetta structure of GB98-T25I shows a 3a fold
with a-helices at residues 9–23, 28–34, and 39–52 and disor-
dered regions at the N and C termini similar to GA98 (Figures
1C and 2A). The main differences from GA98, therefore, are
a slightly shorter a2-helix and an a3-helix that is longer by one
residue.
At low contouring of the GB98-T25I
15N HSQC spectrum,
a minor species (5%) was also detected that has cross-peaks
consistent with the alternative 4b+a fold. The minor component
was detected reproducibly in different sample preparations that
were purified on fresh columns, free of possible contaminants.
The NMR peaks of the minor species could not be assignedights reserved
Table 2. Ligand-Binding Data
Mutant GA88 GA95 GA98 GB98 GB98-T25I GB98-T25I,L20A
Fold 3a 3a 3a 4b+a 3a (95%)
4b+a (5%)
4b+a
KD (HSA) 37 (31)
a 30 244 n.b. n.b. n.b.
KD (IgG) n.b. n.b. 62 <1
b 15 <1b
Dissociation constants are in micromolar units. The experimental error is
estimated to be ± 30%. All binding measurements were done at 15C
except those for GB98-T25I, which were done at 5
C. n.b., no binding
detected.
a Value in parentheses is from isothermal titration calorimetry (see also
Figure S3).
b All GB protein was bound even at the lowest IgG concentrations used.
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Figure 4. 15N HSQC Spectra of GB98-T25I at Low Contour Level
(A) Peaks due to the major 3a state of GB98-T25I are labeled in black. Other
unlabeled low-intensity peaks indicate the presence of a minor species.
(B) Overlay with the 15N HSQC spectrum of GB98 (red).
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Switching Protein Folds and Functionsdirectly because of the low intensity levels of these signals.
However, the pattern of 15N HSQC peaks observed is very
similar (but not identical) to that of GB98 (Figure 4). Indeed the
differences from the GB98 spectrum are consistent with the
incorporation of the T25I mutation. Two main lines of evidence
indicate that the minor 4b+a species is in equilibrium with the
major 3a species. Notably, changing the buffer from 100 mM
KPi, pH 7.0, to 50 mM Tris, pH 8.0, leads to only the major 3a
conformer within NMR detection limits - this process is revers-
ible. Thus the minor 4b+a state cannot be an impurity or result
from a covalent modification. Other evidence of equilibrium
between the major and minor components comes from ligand-
binding experiments (described later). The data therefore indi-
cate that both the 3a and 4b+a folds are detectably populated
for the GB98-T25I sequence and that these two species are in
slow exchange on the NMR time scale. This is similar to the
case of lymphotactin where two different folds with identical
amino acid sequences are in equilibrium and can be detected
simultaneously in HSQC spectra (Tuinstra et al., 2008). Attempts
to observe crosspeaks due to exchange between the two
GB98-T25I conformations either in NOE spectroscopy (NOESY)
or zz-exchange experiments were unsuccessful, presumably
because of the low relative population of the minor 4b+a state
as well as the low solubility of the protein.
GB98-T251/L20A (4b+a)
Wedetermined the structure of GB98-T25I,L20A, the final mutant
in this series, using an extensive set of NOE and torsion angle
restraints. The NMR structures show that mutation of a single
amino acid, L20A, in the GB98-T25I sequence leads to switching
from a predominantly (95%) 3a fold in GB98-T25I to a 4b+a fold
in GB98-T25I,L20A. The GB98-T25I,L20A structure is similar to
other 4b+a structures in this series (Figure 2B; Table S2).
Ligand Binding
NMR spectroscopy was used to measure IgG and HSA binding
to GA and GB high-identity proteins, and the results are summa-
rized in Table 2, Figure 5, and Figure S2. The dissociation
constant (KD) obtained by NMR for binding between GA88 and
HSA was also compared with the KD from isothermal titration
calorimetry and found to be in good agreement (Figure S3).Structure 20, 28The 4b+a folded proteins, GB98 and GB98-T25I,L20A, bind to
the wild-type ligand, IgG, with high affinity (KD < 1 mM). The other
designed GB proteins with 4b+a folds, ranging from GB77 to
GB95, also bind to IgG tightly. None of the GB proteins, including
GB98 and GB98-T25I,L20A, show any detectable binding to the
GA ligand, HSA.
In contrast, the GA proteins do not bind their wild-type ligand,
HSA, as robustly, with binding affinity to HSA decreasing as
identity to GB is increased. Thus, GA88 binds HSAwith a dissoci-
ation constant of 31–37 mM, whereas GA98 has a considerably
weaker affinity with a KD of 244 mM. In addition to decreased
affinity for HSA, the GA proteins acquire affinity for the GB ligand,
IgG, when the sequence identity is increased to 98%. Therefore,
GA98 is bifunctional with weak binding affinity to its cognate
ligand HSA and approximately fourfold tighter binding to IgG
(KD 62 mM).
The GB98-T25I mutant is similar to GA98 in that it also binds
IgG, despite adopting a predominantly 3a fold in the unbound
state. However, binding to IgG is approximately fourfold tighter
than seen for GA98, and there is no detectable binding to HSA.
The tighter binding to IgG corresponds with a higher level of
the alternative 4b+a state in GB98-T25I than in GA98. In GB98-
T25I, the minor 4b+a state is detectable in the HSQC spectrum
(Figure 4) at a level of5%, whereas the 4b+a conformer cannot
be observed in the HSQC spectrum of GA98. Based on the rela-
tive IgG-binding constants for GA98 (KD62 mM) and GB98-T25I
(KD15 mM), the 4b+a state is therefore estimated to be at a level
of approximately 1% in GA98. Thus, the binding results support
the assumption that IgG binding only occurs through the 4b+a
fold, where the engineered IgG-binding epitope is revealed.
Ligand-induced fold switching would then presumably occur
through IgG binding to the weakly populated 4b+a state, driving
the equilibrium from the 3a to the 4b+a conformer. Further
experiments to test this assumption are in progress.
DISCUSSION
Structural Basis for Fold Switching
The three mutation sites described here that are responsible for
fold switching are not localized in one specific part of the 3a or
4b+a structures but rather are spread over several different
structural elements. In the 3a fold, the switching loci correspond
to amino acid changes in the a3-helix (L45Y), the a1-a2 loop3–291, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 287
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Figure 6. Structural Basis for Switching between 3a and 4b+a Folds
(A) A representative NMR structure of GA98 showing L45 and nearest neigh-
bors (pale orange) described in the text. The side chain conformation of Y45
(green) in the GB98-T25I CS-Rosetta structure is superimposed for compar-
ison purposes.
(B) GB98 NMR structure highlighting Y45 and adjacent amino acids.
(C) NMR structure of GB98 showing T25 and surrounding residues (pale
orange). The I25 side chain (green) in the NMR structure of GB98-T25I,L20A is
superimposed for comparison.
(D) CS-Rosetta structure of GB98-T25I highlighting I25 and neighboring
hydrophobic contacts (pale orange). The corresponding position of T25 in
GA98 (green) is superimposed.
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Figure 5. Ligand-Binding Curves
(A) HSA-binding curves for GA88 (filled circles), GA95 (open squares), andGA98
(filled triangles).
(B) IgG-binding curves for GB98-T25I (filled circles) and GA98 (open squares).
(See also Figure S2.)
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Switching Protein Folds and Functions(T25I), and the a1-helix (L20A), whereas in the 4b+a fold, these
mutations are in the b3 strand, the a-helix, and the b2 strand,
respectively. Most of the mutation sites, with the exception of
L20 in the 3a fold, occur on the periphery of the 3a or 4b+a cores.
As such, the resulting changes in stability are generally small
(in an absolute sense) but nonetheless can have a significant
impact on the fold outcome because of the low stability
(DGu 1.5-2.5 kcal/mol) of the high-identity proteins. The extent
to which each state is populated will depend on the relative
energy levels of the 3a and 4b+a conformations. The large shifts
in equilibrium between these two states can best be understood
by considering the effects of the mutations on the two folds,
destabilizing one structure while simultaneously stabilizing the
alternative conformer in this binary system.
In GA98, the L45Ymutation destabilizes the 3a conformation in
the following way. The L45 side chain is not buried in the core but
rather packs against it, making stabilizing hydrophobic contacts
with the core residues I33 and I49 as well as with the more
exposed L32 and Y29 side chains (Figures 3A and 6A). When
L45 is mutated to Y45, these relatively small stabilizing interac-
tions are mostly lost, as the more rigid tyrosine side chain with
its fewer rotational degrees of freedom cannot pack as efficiently
against the 3a core as a leucine. At the same time, the L45Y
mutation also stabilizes the 4b+a conformation of GB98 through288 Structure 20, 283–291, February 8, 2012 ª2012 Elsevier Ltd All ra favorable hydrophobic interaction between the aromatic rings
of Y45 in the b3 strand and the core F52 residue in the b4 strand
(Figure 6B). Further stabilizing hydrogen bond interactions from
Y45-hOH to the D47-carboxylate and to the hydroxyl group of
Y3 in the b1 strand are also likely based on the GB98 NMR
ensemble of structures. Thus, the destabilization of the 3a
conformation is small but significant because of the low stability
of GA98. The relative gain in stability of the 4b+a fold is enough to
shift the equilibrium to this state almost completely (99%).
Introduction of a T25I mutation into GB98 produces GB98-
T25I, which populates mostly (95%) the 3a state with a small
amount (5%) of the 4b+a conformer. Inspection of the GB98
structure gives insights into the destabilizing influence of the
T25I mutation on the 4b+a fold. The T25 residue in GB98 is
located near the N terminus of the a-helix and has closest prox-
imity to the L20, V21, andD22 side chains (Figure 6C), with a likely
H-bonding interaction between the T25-gOH group and the
carboxylate of D22. Loss of this H-bond in a T25I mutant willights reserved
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Switching Protein Folds and Functionstherefore destabilize the 4b+a fold. This is consistent with earlier
stability studies on GB77, which showed that a T25I mutation
decreased the Tm by 4.4
C (Alexander et al., 2009). However,
the destabilizing effect of the T25I mutation is probably larger
in GB98 because of additional unfavorable steric interactions
that are likely to exist between the adjacent branched side
chains of I25 and L20.
In contrast, the T25I mutation stabilizes the 3a fold of GB98-
T25I. While CS-Rosetta only models the positions of the side
chains shown in Figure 6D, their conformations are similar to
those obtained in related NMR structures and provide a useful
guide for discussing mutational effects. In the CS-Rosetta struc-
ture of GB98-T25I, the side chains in the region of the T25I
mutation have an average heavy atom RMSD of 1.6 ± 0.5 A˚ in
the ensemble. These side-chain arrangements have average
RMSDs of 1.5–1.9 A˚ when compared with their corresponding
positions in both NMR (He et al., 2008; Alexander et al., 2009)
and CS-Rosetta (Shen et al., 2010) structures of GA88 and
GA95. Thus, I25 is located in the loop between the a1- and a2-
helices of the GB98-T25I 3a fold, and examination of the CS-
Rosetta structure suggests that I25 contributes more extensively
to the hydrophobic core than a threonine residue. A similar stabi-
lizing conformation is also seen for I25 in GA88 (He et al., 2008).
The putatively stabilizing hydrophobic interactions involving I25
and neighboring residues L20, A23, I49, and F52 (Figure 6D)
counteract the known destabilizing influence of having Y45 in
the a3-helix so that this sequence adopts a predominantly 3a
conformation. The GB98-T25I mutant is the only case so far
where both folds are detectable by NMR; therefore, the 4b+a
and 3a conformations of this amino acid sequence must be
the closest in energy of the four mutants in this series.
The third fold switch involves an L20A mutation in the a1-helix
of GB98-T25I. L20 is completely buried in the hydrophobic core
of the 3a conformation of GB98-T25I (Figure 6D). Conversion to
alanine at this position decreases packing interactions with other
neighboring residues contributing to the core such as A16, I25,
and I49, thereby destabilizing the 3a fold. Indeed this is the
most destabilizing of the three mutations in this study because
the L20A mutation cannot be tolerated even in more stable 3a
mutants such asGA77 (Tm 77
C) and leads to an unfolded protein
(Alexander et al., 2009). In the 4b+a conformer, mutation to the
smaller A20 residue lowers the energy of this state by removing
unfavorable steric contacts that would otherwise exist between
the proximal L20 and I25 side chains. Thus, the equilibrium is
shifted almost completely (>95%) to the 4b+a fold with an
L20A substitution. GB98-T25I,L20A is the most stable mutant
in this series (Tm 46C) and therefore must have the largest
energy gap between 4b+a and 3a states of any of the proteins
studied here.
Gain and Loss of Function
The ligand-binding study provides insights into how folds and
functions can evolve. In particular, a new IgG-binding function
is gained in GA98 before complete loss of the original HSA-
binding function. Bifunctional mutants such as GA98 therefore
serve as transitory species between distinct functional states.
Moreover, the new IgG-binding function of GA98 is detectable
before there is significant population of the corresponding
4b+a fold. This stems from the intrinsically tight binding of IgGStructure 20, 28to GB sequences adopting the 4b+a conformation. In this way,
even low levels of the 4b+a fold in the unbound states of GA98
(1%) and GB98-T25I (5%) can lead to IgG binding, with KD
values of 62 and 15 mM, respectively (Table 2). Thus, increased
equilibrium amounts of the 4b+a state in samples with predom-
inantly 3a conformers correlate with a gain of IgG-binding
function.
In contrast, the baseline HSA affinity of GA88 is at least 30-fold
weaker than IgG affinity to the 4b+a proteins GB98 and GB98-
T25I,L20A. Much of this loss in affinity is due to the mutation of
A52F, which apparently alters the contact with HSA. Further
loss of HSA-binding function occurs in GA98 and GB98-T25I,
even though 3a levels are still high. The drop in HSA affinity
from GA95 to GA98 is primarily due to a decrease in protein
stability, as the only amino acid change (I30F) is located away
from the HSA-binding epitope (Lejon et al., 2004; He et al.,
2007) at the a2-a3 surface (Figure 3A). In the case of GB98-
T25I, the complete loss of HSA-binding function is mainly due
to the presence of a tyrosine residue at position 45 (Figure 1C).
Even in other more stable 3a mutants, changing leucine to tyro-
sine at residue 45 was found to abolish HSA binding. This is
consistent with the observation that L45 is centrally located in
the binding interface between HSA and a variant of wild-type
GA (He et al., 2007).
The results here demonstrate that the mode for fold switching
is not unique but can occur in multiple ways, thus increasing the
probability for such events. These large-scale structural changes
can occur through a series of single amino acid substitutions,
once a suitable high-sequence identity background has been
reached. The present study uses only binary sequence space
(either GA or GB amino acids) and is not exhaustive, so it is likely
that other switch mutants also exist. Expansion to the complete
range of amino acids may further increase the number of single
amino acid switch mutants and could also potentially lead to
other folds and functions. Indeed, recent theoretical studies
suggest that the high-identity GA/GB sequences may be capable
of adopting numerous other fold topologies (Cao and Elber,
2010).
It is possible that the in vitro-directed evolution of the GA/GB
system may reflect some aspects of the in vivo evolution of the
GA and GB domains in protein G. Protein G is a multidomain
protein with two to three copies of each of the GA and GB
domains. One plausible hypothesis based on our results is
that a duplicated HSA-binding GA domain evolved the IgG-
binding function through fold switching. In such a multidomain
system, the likelihood that this could occur seems high, because
functionality would be gained with no loss of fitness (due to the
multiple copies). Other multidomain proteins may therefore
provide further examples where fold switching has occurred.
EXPERIMENTAL PROCEDURES
Mutagenesis
We prepared mutants with a QuikChange (Stratagene) kit using the manufac-
turer’s protocol.
Protein Expression and Purification
GA and GB mutants were cloned into a vector encoding an N-terminal subtil-
isin-prodomain fusion tag system (Profinity eXact, Bio-Rad) described previ-
ously (Ruan et al., 2004). Escherichia coli BL21(DE3) cells were transformed3–291, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 289
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Switching Protein Folds and Functionswith this vector, and cells were grown at 25C to a density of 0.6–0.8 OD600 in
M9 minimal media for 13C and 15N labeling. Protein expression was induced
with 1 mM IPTG, and the cells were grown a further 6 hr at 25C. The culture
was then centrifuged, and the cells were suspended in 100 mM KPi buffer
(pH 7.0) and then sonicated. The cleared cell extract was loaded on to a
5-ml eXact column at 5 mL/min and then washed extensively with 100 mM
potassium phosphate buffer (pH 7.0). The pure target protein was cleaved
and eluted with an injection of 6 ml of a solution containing 10 mM sodium
azide and 100 mM potassium phosphate (pH 7.0) at 0.5 mL/min. Purified
samples were then concentrated for NMR analysis.
NMR Spectroscopy
Isotope-labeled samples were prepared at concentrations of 0.05–0.3 mM for
NMR analysis in 100 mM potassium phosphate buffer (pH 7.0) containing 5%
D2O. NMR spectra were acquired on a Bruker AVANCE 600MHz spectrometer
with cryoprobe. Spectra were processed with NMRPipe (Delaglio et al., 1995)
and analyzed with Sparky (Goddard and Kneller, 2004). Backbone resonances
were assigned with HNCA, HN(CO)CA, HN(CA)CO, HNCO, HNCACB, and
CBCA(CO)NH experiments. Aliphatic side-chain assignments were obtained
with (H)C(CO)NH-TOCSY and H(CCO)NH-TOCSY spectra, while aromatic
resonances were assigned with two-dimensional (2D) CBHD/CBHE and
NOESY spectra. We measured NOEs using 3D 15N NOESY and aliphatic
and aromatic 3D 13C NOESY spectra.
Ligand Binding
Free and bound states were in slow exchange on the NMR time scale; hence,
peaks due to the high molecular weight bound states were broadened beyond
detection. Therefore, binding was determined by measuring the decay in peak
intensity of amide protons in 15N HSQC spectra of GA or GBmutants as a func-
tion of ligand concentration. In a typical binding experiment, the 15N-labeled
protein was approximately 50 mM, and ligand concentrations ranging from
0.1 to 8.0 molar equivalents were used depending on binding affinity. Control
experiments were also carried out to determine howmuch of the peak intensity
decay was due to an increase in solution viscosity from added IgG or HSA.
This was done by adding increasing concentrations of IgG or HSA to a
known nonbinder and measuring the decrease in amide peak intensities.
Thus, the viscosity affect of IgG was determined by adding IgG to the non-
binder, 15N-labeled PSD-1, a variant of wild-type GA (He et al., 2006). Similarly,
HSA was added to the nonbinder, 15N-labeled wild-type GB, to determine the
HSA viscosity affect. Amide intensity decay curves due to binding were then
corrected for the viscosity affect.
Structure Calculations and Analysis
We determined NMR structures for GA98, GB98, and GB98-T25I,L20A using
CNS 1.1 (Bru¨nger et al., 1998). Assignment of NOEs was assisted with an
in-house program, NOEID. Interproton NOE distance restraints were classified
as strong (1.8–3.0 A˚), medium (1.8–4.0 A˚), weak (1.8–5.0 A˚), and very weak
(2.8–6.0 A˚). TALOS (Cornilescu et al., 1999) was used to provide backbone
dihedral restraints from chemical shift data. Hydrogen bond restraints were
incorporated in the latter stages of refinement. The final ensemble of 20 struc-
tures was chosen based on low total energy, no NOE distance violations
>0.3 A˚, no dihedral angle violations >5, and other parameters shown in Table
1. Structures were analyzed with PROCHECK-NMR (Laskowski et al., 1996),
PyMol (Delano, 2002), and MOLMOL (Koradi et al., 1996). We used the stan-
dard CS-Rosetta3.2 protocol (Shen et al., 2008) to determine the GB98-T25I
structure based on chemical shifts. One thousand CS-Rosetta models were
generated, and the 10 lowest energy models clustered with a backbone
RMSD of 1.00 ± 0.27 A˚.
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